{"DataElement":{"publicId":"5589293","version":"1","preferredName":"Neoplasm Mutation Abnormality Technique Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._A practiced and regimented skill or series of actions._Something distinguishable as an identifiable class based on common qualities.","longName":"TMB_Technique","context":"PBTC","contextVersion":"1","DataElementConcept":{"publicId":"5584330","version":"1","preferredName":"Neoplasm Mutation Abnormality Technique","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._A practiced and regimented skill or series of actions.","longName":"5584242v1.0:2231639v1.0","context":"PBTC","contextVersion":"1","ObjectClass":{"publicId":"5584242","version":"1","preferredName":"Neoplasm Mutation Abnormality","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","longName":"C3262:C45576","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"429EED09-9A7A-6319-E053-F662850A5BFB","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-01","modifiedBy":"ONEDATA","dateModified":"2016-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2231639","version":"1","preferredName":"Techniques","preferredDefinition":"Scientific or clinical procedures and methods.","longName":"C16847","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Technique","conceptCode":"C16847","definition":"A practiced and regimented skill or series of actions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8B9B8C1-3A97-5A6E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-04","endDate":null,"createdBy":"UMLLOADER_CADSR","dateCreated":"2005-06-04","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435033","version":"1","preferredName":"Techniques","preferredDefinition":"A practiced and regimented skill or series of actions.","longName":"C16847","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87DA-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"429F9451-D868-6969-E053-F662850AFED7","latestVersionIndicator":"Yes","beginDate":"2016-12-01","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-01","modifiedBy":"RICHARDS","dateModified":"2016-12-01","changeDescription":"PBTC slr120116","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5589181","version":"1","preferredName":"Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5589181v1.0","context":"PBTC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, Specify","valueDescription":"Other Specify","ValueMeaning":{"publicId":"4188777","version":"1","preferredName":"Other Specify","longName":"4188777","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Be specific about something; define clearly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3CC9DDB-CE4D-9879-E040-BB89AD430A03","latestVersionIndicator":"Yes","beginDate":"2014-03-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42EF0CA8-7AE2-428B-E053-F662850A6B69","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Lynch Syndrome by germline gene sequencing","valueDescription":"Germline Genotype Testing Lynch Syndrome","ValueMeaning":{"publicId":"5589290","version":"1","preferredName":"Germline Genotype Testing Lynch Syndrome","longName":"5589290","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lynch Syndrome","conceptCode":"C8494","definition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EF0CA8-7AEF-428B-E053-F662850A6B69","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42EF0CA8-7B08-428B-E053-F662850A6B69","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"Intermediate mutation burden (6-19) by Foundation One","valueDescription":"Genomic Profile Intermediate Mutation Abnormality Burden","ValueMeaning":{"publicId":"5589291","version":"1","preferredName":"Genomic Profile Intermediate Mutation Abnormality Burden","longName":"5589291","preferredDefinition":"Information about all the genes in an organism, including variations, gene expression, and the way those genes interact with each other and with the environment. A genomic profile may be used to discover why some people get certain diseases while other people do not, or why people respond differently to the same drug.: Lying between two extremes in time or space or degree.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.: The quantity of something that is borne or carried by an individual or population.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genomic Profile","conceptCode":"C94411","definition":"Information about all the genes in an organism, including variations, gene expression, and the way those genes interact with each other and with the environment. A genomic profile may be used to discover why some people get certain diseases while other people do not, or why people respond differently to the same drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Intermediate","conceptCode":"C73705","definition":"Lying between two extremes in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Burden","conceptCode":"C85883","definition":"The quantity of something that is borne or carried by an individual or population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EF0CA8-7B17-428B-E053-F662850A6B69","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42EF0CA8-7B30-428B-E053-F662850A6B69","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"High mutation burden (greater than or equal to 20) by Foundation One","valueDescription":"Genomic Profile High Mutation Abnormality Burden","ValueMeaning":{"publicId":"5589292","version":"1","preferredName":"Genomic Profile High Mutation Abnormality Burden","longName":"5589292","preferredDefinition":"Information about all the genes in an organism, including variations, gene expression, and the way those genes interact with each other and with the environment. A genomic profile may be used to discover why some people get certain diseases while other people do not, or why people respond differently to the same drug.: An elevated level or position or degree; greater than normal in degree or intensity or amount.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.: The quantity of something that is borne or carried by an individual or population.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genomic Profile","conceptCode":"C94411","definition":"Information about all the genes in an organism, including variations, gene expression, and the way those genes interact with each other and with the environment. A genomic profile may be used to discover why some people get certain diseases while other people do not, or why people respond differently to the same drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"High","conceptCode":"C25227","definition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Burden","conceptCode":"C85883","definition":"The quantity of something that is borne or carried by an individual or population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EF0CA8-7B3F-428B-E053-F662850A6B69","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"444329EB-AD6C-6710-E053-F662850A4EE0","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-22","modifiedBy":"ONEDATA","dateModified":"2016-12-22","deletedIndicator":"No"},{"value":"CMMRD by genome wide sequencing greater than 100 non-synonymous coding regions","valueDescription":"Greater Than Non-synonymous Coding SNP Germline Genotype Testing Integer Constitutional Mismatch Repair Deficiency Syndrome","ValueMeaning":{"publicId":"5589227","version":"1","preferredName":"Greater Than Non-synonymous Coding SNP Germline Genotype Testing Integer Constitutional Mismatch Repair Deficiency Syndrome","longName":"5589227","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A Non-synonymous Coding SNP consists of a variation at an appreciable frequency between individuals of a single interbreeding population of a single nucleotide, due to base substitution, at an equivalent location within a protein-coding region of a gene that causes an alteration of the translation of the affected codon into a different amino acid in the protein product. A missense non-synonymous SNP results in an amino acid change in the protein product due to a codon change, while a nonsense non-synonymous SNP results in a termination codon.: An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A number with no fractional part, including the negative and positive numbers as well as zero.: A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Non-synonymous Coding SNP","conceptCode":"C45397","definition":"A Non-synonymous Coding SNP consists of a variation at an appreciable frequency between individuals of a single interbreeding population of a single nucleotide, due to base substitution, at an equivalent location within a protein-coding region of a gene that causes an alteration of the translation of the affected codon into a different amino acid in the protein product. A missense non-synonymous SNP results in an amino acid change in the protein product due to a codon change, while a nonsense non-synonymous SNP results in a termination codon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Constitutional Mismatch Repair Deficiency Syndrome","conceptCode":"C130202","definition":"A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42ED6358-6983-701F-E053-F662850ADF5C","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42ED6358-699C-701F-E053-F662850ADF5C","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"CMMRD by germline gene sequencing","valueDescription":"Germline Genotype Testing Constitutional Mismatch Repair Deficiency Syndrome","ValueMeaning":{"publicId":"5589183","version":"1","preferredName":"Germline Genotype Testing Constitutional Mismatch Repair Deficiency Syndrome","longName":"5589183","preferredDefinition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Constitutional Mismatch Repair Deficiency Syndrome","conceptCode":"C130202","definition":"A rare childhood cancer predisposition syndrome caused by biallelic inheritance of mutations in MLH1, MSH2, MSH6, or PMS2 genes. It is characterized by the development of childhood cancers, usually hematological malignancies and/or brain tumors, and colorectal cancers with multiple intestinal polyps. The majority of patients show signs of neurofibromatosis type 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB0E0C-D667-18EE-E053-F662850A9771","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"42EB0E0C-D680-18EE-E053-F662850A9771","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"ONEDATA","dateModified":"2016-12-05","deletedIndicator":"No"},{"value":"High mutation burden by genome wide sequencing showing greater than 100 non-synonymous coding regions","valueDescription":"High Mutation Abnormality Germline Genotype Testing Greater Than 100 Non-synonymous Coding SNP Burden","ValueMeaning":{"publicId":"6064152","version":"1","preferredName":"High Mutation Abnormality Germline Genotype Testing Greater Than 100 Non-synonymous Coding SNP Burden","longName":"6064152","preferredDefinition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.: Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.: An assay used to determine the genes and molecular markers present in the germline DNA of an individual.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::100: A Non-synonymous Coding SNP consists of a variation at an appreciable frequency between individuals of a single interbreeding population of a single nucleotide, due to base substitution, at an equivalent location within a protein-coding region of a gene that causes an alteration of the translation of the affected codon into a different amino acid in the protein product. A missense non-synonymous SNP results in an amino acid change in the protein product due to a codon change, while a nonsense non-synonymous SNP results in a termination codon.: The quantity of something that is borne or carried by an individual or population.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High","conceptCode":"C25227","definition":"An elevated level or position or degree; greater than normal in degree or intensity or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Germline Genotype Testing","conceptCode":"C118383","definition":"An assay used to determine the genes and molecular markers present in the germline DNA of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Non-synonymous Coding SNP","conceptCode":"C45397","definition":"A Non-synonymous Coding SNP consists of a variation at an appreciable frequency between individuals of a single interbreeding population of a single nucleotide, due to base substitution, at an equivalent location within a protein-coding region of a gene that causes an alteration of the translation of the affected codon into a different amino acid in the protein product. A missense non-synonymous SNP results in an amino acid change in the protein product due to a codon change, while a nonsense non-synonymous SNP results in a termination codon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Burden","conceptCode":"C85883","definition":"The quantity of something that is borne or carried by an individual or population.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64BB920B-549C-6C96-E053-F662850A9A25","latestVersionIndicator":"Yes","beginDate":"2018-02-08","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-02-08","modifiedBy":"ONEDATA","dateModified":"2018-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64BB920B-54B5-6C96-E053-F662850A9A25","beginDate":"2018-02-08","endDate":null,"createdBy":"RICHARDS","dateCreated":"2018-02-08","modifiedBy":"ONEDATA","dateModified":"2018-02-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EB0E0C-D625-18EE-E053-F662850A9771","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"RICHARDS","dateModified":"2018-02-08","changeDescription":"PBTC slr 120516","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Mutation Burden  Techni","type":"Preferred Question Text","description":"Tumor Mutation Burden  Technique","url":null,"context":"PBTC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42EE4D63-F2E9-54BA-E053-F662850A74AA","latestVersionIndicator":"Yes","beginDate":"2016-12-05","endDate":null,"createdBy":"RICHARDS","dateCreated":"2016-12-05","modifiedBy":"RICHARDS","dateModified":"2018-02-08","changeDescription":"PBTC slr 120516","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}